Eli Lilly said it plans to submit the pill to the Food and Drug Administration for approval as a weight loss medication this ...

Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...

In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 ...

A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...

Past research has found that Ozempic may have more health beyond weight loss and weight management. Now, three new studies ...

Three new studies suggest that Ozempic and related diabetes and weight loss drugs may help protect the brain from strokes.

Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 global studies. Researchers found that although these medications, including ...

Eli Lilly’s weight-loss pill, orforglipron, shows promising results in trials, offering a needle-free alternative to injectables like Ozempic and Mounjaro. In a major study, people who took the drug ...

Eli Lilly says it plans to apply for U.S. Food and Drug Administration (FDA) approval by the end of the year to market the ...

Could popular diabetes and weight loss drugs like Ozempic actually protect your brain from stroke damage, or prevent strokes altogether? Three new studies presented at a major neurosurgery conference ...